Adults with type 2 diabetes receiving tirzepatide had significantly greater declines in urine albumin-to-creatinine ratio ...

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

GLP-1 drugs such as semaglutide and tirzepatide are at the center of a weight-loss drug revolution. The biggest development in weight-loss medicine since bariatric surgery (not to mention less ...

Medications like semaglutide and tirzepatide have gained significant attention for their impressive weight-loss effects, but they do much more than just helping you shed pounds. Let’s dive into ...

Semaglutide has been shown to reduce the risk of complications in patients with chronic kidney disease, an indication for which it has been filed for approval, while tirzepatide has been shown to ...

Tirzepatide will be protected from inclusion in the negotiation list until 2030, as it was first approved in 2022, while semaglutide has been on the market since 2017. There was no word from Novo ...

The rationale for the study, according to the authors, is that “Nearly 2% of the US population received a prescription for ...

Moran Eye Center at the University of Utah have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide and tirzepatide drugs ...

Other obesity drugs in development have also shown early, but promising results that might overshadow both tirzepatide and semaglutide. Another consideration is cost. The current lower-dose ...

GLP-1 drugs such as semaglutide and tirzepatide are at the center of a weight-loss drug revolution. The biggest development in weight-loss medicine since bariatric surgery (not to mention less ...

So, how does Mounjaro work? Tirzepatide works similarly to semaglutide. The difference here is that tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist and a GLP-1 ...